HRT: New data, continuing controversies

Patient Care

Volumn 32, Issue 20, 1998, Pages 92-109

  D'Epiro, Nancy Walsh ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0141531165     PISSN: 0031305X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 1998;280:605-613.
2. Petitti DB. Hormone replacement therapy and heart disease prevention: experimentation trumps observation [editorial]. JAMA. 1998;280:650-651.
3. The Writing Group for the PEPI trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Post-menopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA. 1995;273:199-208.
4. Sorensen KE, Dorup I, Hermann AP, et al. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function. Circulation. 1998;97:1234-1238.
5. Yaffe K, Sawaya G, Lieberburg I, et al. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA. 1998;279:688-695.
6. Yaffe K, Grady D, Pressman A, et al. Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women. J Am Geriatr Soc. 1998;46:816-821.
7. Sarrel PM, Lufkin EG, Oursler MJ, et al. Estrogen actions in arteries, bone, and brain. Sci Am Sci Med. 1994;1:44-53.
8. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992;117:1016-1037.
9. Cauley JA, Seeley DG, Browner WS, et al. Estrogen replacement therapy and mortality among older women: the study of osteoporotic fractures. Arch Intern Med. 1997;157:2181-2187.
10. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer. Lancet. 1997;350:1047-1059.
11. Col NF, Eckman MH, Karas RH, et al. Patient-specific decisions about hormone replacement therapy in postmenopausal women. JAMA. 1997;277: 1140-1147.